Navigation Links
Leica Microsystems Debuts First 3D Surgical Microscopes with TrueVision® Technology Inside, at AANS Annual Meeting in New Orleans
Date:4/29/2013

Wetzlar, Germany / Santa Barbara, CA (PRWEB) April 29, 2013

Leica Microsystems and TrueVision® 3D Surgical announced the debut of 3D surgical microscopes at the 81st Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS). By incorporating the digital smart 3D system inside select models of Leica surgical microscopes, Leica Microsystems and TrueVision have eliminated the need for a separate 3D cart. Surgeons can control the 3D recording functions, without interrupting their workflow, via the microscope hand and foot controls, and OR staff will benefit from easier, faster setup and more space to maneuver in the operating room. The TrueVision 3D platform is also upgradable to support future surgical guidance applications.

Leica Microsystems will be presenting two 3D microscope systems, the Leica M720 OH5 and Leica M525 OH4 with TrueVision® technology inside at this year’s Annual Scientific Meeting of the AANS in New Orleans, April 27th to May 1st, 2013. Surgeons will be able to preview the systems during AANS exhibit hours in Leica Microsystems’ booth #639. On Monday and Tuesday April 29th and 30th, 9:15 am, Burton Tripathi, PhD, CTO and EVP of TrueVision, will be presenting “Digital Convergence: Bringing 3D Imaging to Neurosurgery” in the Leica exhibit theater in booth #639.

Eoghan O’Lionaird, President, Leica Microsystems, commented: “These 3D surgical microscopes are the result of a very fruitful collaboration between Leica Microsystems and TrueVision. These products represent another milestone in Leica’s history of technological innovation in the field of surgical microscopy. For the first time ever, neurosurgeons will have access to a surgical microscope with a fully integrated, digital 3D system built inside.”

“At MD Anderson, world-class neurosurgical education has been elevated by the incorporation of Leica and TrueVision 3D,” says Dr. Nicholas B. Levine, Prof
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Leica Biosystems and Synthon Biopharmaceuticals Partner to Develop a Companion Diagnostic Program for Targeted Cancer Therapies
2. Research Triangle Region Debuts Talent Attraction Campaign at BIO 2012
3. Micropharma announces timeline to commercial launch of worlds first ingestible gastrointestinal sampling device
4. SENOMYX ANNOUNCES CORPORATE UPDATE AND FIRST QUARTER FINANCIAL RESULTS
5. Cytos Biotechnology Ltd Reports First Quarter 2013 Financial Results and Recent Development
6. InterMune Reports First Quarter 2013 Financial Results and Business Highlights
7. Dedication to the Medical Industry - The First International PEEK Meeting
8. Plandai Biotechnology, Inc. Announces Shipment Of First Machinery To South African Production Facility
9. AMRI to Announce First Quarter Results
10. Cell Therapeutics to Report First Quarter Financial Results after Market on May 2, 2013
11. Cepheid Reports 2013 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014 Robert Harman, DVM, Founder and CEO ... proud to announce the relaunch of his highly informative blog, ... series called “ What are Stem Cells ?” Dr. ... straightforward foundation in the basics of stem cell therapy so ... right type of treatment when considering regenerative medicine. , A ...
(Date:7/10/2014)... , July 10, 2014 On ... Dmitry Medvedev , presented Russia,s ... BIOCAD . The Company is developing a unique project ... project BIOCAD develops a number of innovative drugs based ... diseases. The ceremony took place at the International Exhibition ...
(Date:7/10/2014)... to the International Atomic Energy Agency (IAEA) the ... acquiring sufficient quantities of plutonium or highly enriched ... device. The IAEA also notes that most cases ... which can be challenging to detect with most ... appearing this week in the Journal of ...
(Date:7/10/2014)... Hall effect in bilayer graphene and shown that this ... electric field. , The fractional quantum Hall effect, ... are exposed to large magnetic fields, is a striking ... behave as a single system. However, while the basic ... of this collective behavior remain not well understood, in ...
Breaking Biology Technology:Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2Sensitive detection method may help impede illicit nuclear trafficking 2Columbia researchers observe tunable quantum behavior in bilayer graphene 2Columbia researchers observe tunable quantum behavior in bilayer graphene 3
... Ill., Jan. 5, 2012 Baxter International Inc. ... in a Phase I clinical trial of its ... form of a full-length recombinant factor VIII (rFVIII) ... [Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method] full-length rFVIII molecule ...
...  ZyGEM Corp. Ltd., a developer and marketer of ... other nucleic acids, and the US Army Medical ... the signing of a Cooperative Research and Development ... processing solutions for biothreat agents.  The two organizations ...
... Spine, LLC, a medical device company focused on developing ... degenerative disc disease, today announced a 46% sales increase ... the revenue improvement, RSB Spine Chief Executive Officer John ... rewarding considering the overall spine market contraction in 2011, ...
Cached Biology Technology:Baxter Initiates Phase I Clinical Trial of Longer-acting Recombinant FVIII Treatment for Hemophilia A 2Baxter Initiates Phase I Clinical Trial of Longer-acting Recombinant FVIII Treatment for Hemophilia A 3Baxter Initiates Phase I Clinical Trial of Longer-acting Recombinant FVIII Treatment for Hemophilia A 4Baxter Initiates Phase I Clinical Trial of Longer-acting Recombinant FVIII Treatment for Hemophilia A 5ZyGEM and USAMRIID Sign CRADA for Development of Simplified Sample Processing Solutions for Biothreat Agents 2ZyGEM and USAMRIID Sign CRADA for Development of Simplified Sample Processing Solutions for Biothreat Agents 3
(Date:7/11/2014)... WASH. July 11, 2014 Researchers have ... three-dimensional images. The new technology, called Virtual Finger, ... small structures like neurons and synapses using the ... unique technology makes 3D imaging studies orders of ... at an unprecedented level across many areas of ...
(Date:7/11/2014)... evidence has demonstrated that transplantation of mesenchymal stem cells ... or mouse models of Alzheimer,s disease (AD) and improve ... ischemia. Few studies are reported on the therapeutic effect ... AD and on the effect on oxidative injury and ... Yan and her team, School of Life Sciences, Tsinghua ...
(Date:7/11/2014)... is evidence that under the normal circumstances, ... development, maintain neuronal environment, and exhibit therapeutic ... neurodegenerative disease. Previous studies have found that ... after chemical induction have reduced viability, which ... Prof. Xiaodong Yuan, Kailuan General Hospital, Hebei ...
Breaking Biology News(10 mins):Virtual finger enables scientists to navigate and analyze complex 3D images 2
... from Kent State University and the University of ... species Cycloprosopon dobrogea in eastern Romania. Previously unexamined, ... more than 150 million years ago during the ... crabs helps determine various aspects of biodiversity and ...
... St. Paul, Minn. (October 17, 2007) Deadlines ... reservations are quickly approaching for the 2007 National ... Symposium will be held December 12-14, 2007 at ... The 2007 symposium, organized by The American ...
... imagist and researcher at Harvard University,s Initiative in ... the 2007 Lennart Nilsson Award. Frankel was sited ... art and crystal-clear scientific illustrations both fascinating ... community alike. The Lennart Nilsson Award is ...
Cached Biology News:Deadlines for 2007 National Soybean Rust Symposium fast approaching 2Lennart Nilsson Award 2007 2
PGC-1 (H-300)...
Mouse VEGF R1/Flt-1 Phycoerythrin MAb (Clone 141522) Keywords: Receptor Tyrosine Kinase, RTK, VEGFR1, VEGF Receptor 1 Protein Family: Receptor Tyrosine Kinases, VEGF/PDGF Family...
Anti-human CD48/BLAST-1, clone MEM102, Monoclonal Antibody...
Affinity Purified Anti-Human NP-1...
Biology Products: